Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Oct;83(2):337-45.
doi: 10.1111/j.1476-5381.1984.tb16493.x.

Characterization of the adenosine receptor responsible for the inhibition of histamine and SRS-A release from human lung fragments

Characterization of the adenosine receptor responsible for the inhibition of histamine and SRS-A release from human lung fragments

P A Hillyard et al. Br J Pharmacol. 1984 Oct.

Abstract

The inhibitory effects of a range of natural and synthetic derivatives of adenosine on the antigen-induced release of histamine and slow reacting substance of anaphylaxis (SRS-A) from human lung has been studied. The nucleotides ATP, ADP and AMP appear to act by being converted to adenosine. The rank order of inhibitory potency of the synthetic analogues indicates that these compounds act at an extracellular A2/Ra purinoceptor. The xanthines, 1, 3-diethyl-8-phenylxanthine, 8-phenyltheophylline and theophylline antagonized the inhibitory action of N-ethyl-carboxamideadenosine competitively. Theobromine was inactive. This supports the view that the inhibitory receptor is of the A/R type. Hexobendine and dipyridamole, reported to antagonize the uptake of adenosine, failed to modify the response of human lung fragments to adenosine. The P site agonist 2',5' dideoxyadenosine inhibited the release of histamine and SRS-A. This effect was not prevented by the inhibitors of uptake, hexobendine and dipyridamole, nor was it antagonized by 8-phenyltheophylline.

PubMed Disclaimer

References

    1. Fed Proc. 1971 Nov-Dec;30(6):1725-9 - PubMed
    1. Life Sci. 1974 Feb 1;14(3):489-503 - PubMed
    1. Br J Pharmacol. 1974 Oct;52(2):167-74 - PubMed
    1. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5482-6 - PubMed
    1. J Immunol. 1978 Mar;120(3):871-8 - PubMed

MeSH terms